Promoting Human Health
and Well Being
Our Science
Innovation
Merging our understanding of immune therapy with cutting-edge discoveries of how the microbiome functions, Rise is developing targeted immunotherapy drugs to treat a broad range of clinical indications.
Immunology
We design immunological-based drugs to treat chronic diseases including autoimmunity, cancer, and infection.
Read more
Read more
Microbiome
Our understanding of microbiome science drives novel target identification and innovative drug design.
Read more
Read more
Synthetic Biology
We use our proprietary oral biologics delivery technology to engineer novel immunological-directed cellular products.
Read more
Read more
Our Capabilities
PLATFORM
Synthetic Biology Medicine
As a foundational technology, Rise Therapeutics has developed the innovative and proprietary Tripartite X (TPX) drug delivery platform that embraces synthetic biology-based approaches to enable oral delivery of targeted biologic therapy.
INFRASTRUCTURE
Clinical
GMP
Manufacturing
Our clinical GMP drug production capabilities for microbial-based products including Live Biotherapeutic Products (LBPs) enables rapid and efficient translation of innovative bench discoveries towards commercialization.
Our Pipeline
At Rise Therapeutics, our product development focus, in-house clinical GMP manufacturing capabilities, and drug development experience enables us to pursue rapid and efficient novel drug development from innovative laboratory discoveries.
Our Team
Interested in working with Us?
Become a Partner
Rise Therapeutics is interested in evolving key partnerships with leading academic, biotechnology, and pharmaceutical groups that share our interest and commitment to develop innovative new medicines.
Read more
Read more
Join Our Team
We are always looking for extraordinary people with exceptional creativity and enthusiasm. In our collaborative, high performing, and entrepreneurial environment, we work as a team to investigate life saving products and treatments.
Read more
Read more